Pulmonary Arterial Hypertension: Recommendations for Improving Patient Outcomes
Print
Email this page
Created November 1, 2011
Pulmonary Arterial Hypertension Recommendations for Improving Patient Outcomes
日本版 (Japanese Version)
Pulmonary Hypertension Association White Paper Workgroup Members
Rino AldrighettiPresident | Marius M. Hoeper, M.D.Department of Pulmonary MedicineHannover Medical School Hannover, Germany | Noriko MurakamiFounder and PresidentPulmonary Hypertension Association, Japan |
David B. Badesch, M.D.Professor of MedicineClinical Director, Pulmonary Hypertension Center Research Subject Advocate, CTSI Chair, Pharmacy and Therapeutics Committee University of Colorado Denver | Prof. Zhi-Cheng Jing, M.D.Department of Cardio-Pulmonary Circulation | Toru Satoh, M.D.Professor of Medicine |
Karen A. Fagan, M.D.Chief, Division of Pulmonary and CriticalCare Medicine University of South Alabama Mobile, Alabama | Anne Keogh, M.D.Professor in MedicineSenior Heart Transplant Cardiologist Joint Head Clinical Research Victor Chang Research Institute St Vincent's Hospital Sydney, Australia | Rogerio Souza, M.D., Ph.D.Pulmonary DepartmentHeart Institute University of São Paulo Medical School São Paulo, Brazil |
Gerry FischerPresident | Michael McGoon, M.D.Professor of Medicine | Adam Torbicki, M.D., Ph.D.Department of Chest MedicineInstitute of Tuberculosis and Lung Diseases Medical University of Warsaw Warsaw, Poland |
Sean Gaine, M.D., Ph.D.Director, National PulmonaryHypertension Unit Mater Misericordiae University Hospital University College Dublin Dublin, Ireland |
| Attachment | Size |
|---|---|
| pha_white_paper_final.pdf | 1.67 MB |
| pha_white_paper_j_0319.pdf | 1.55 MB |